Opendata, web and dolomites


DNA rEpair impaired Mice with accElerated Neurodegeneration as Tool to Improve Alzheimer therapeutics

Total Cost €


EC-Contrib. €






 Dementia project word cloud

Explore the words cloud of the Dementia project. It provides you a very rough idea of what is the project "Dementia" about.

decline    overexpressing    preclinical    repair    progressive    disorders    50    ad    million    indicating    spectacularly    intervention    classes    rna    complete    people    mice    mutants    represented    resource    huge    worldwide    requirement    fail    generating    unparalleled    plaques    primary    quantitative    tau    transition    qol    poc    therapy    models    beta    connection    prominent    expression    care    combating    ercc1    unprecedented    provides    altered    cognitive    realistic    companies    magnitude    dramatic    syndromes    instrumental    nutritional    age    damage    delta    tangles    opening    discovered    relies    interventions    disclosed    progression    monitoring    lt    valid    fide    socio    erc    identification    biomarkers    alzheimer    neurodegeneration    striking    perspectives    final    characterization    delay    medication    protein    seriously    dna    compartments    aging    poorly    deficient    amyloid    offers    model    mouse    similarities    medical       patients    mainly    pharmaceutical    transgenic    disease    brain    aggregates    despite    genome    bona    neurodegenerative    unmet    profiles    human    economical    mutant    parallels    health    prevention    proteins    context   

Project "Dementia" data sheet

The following table provides information about the project.


Organization address
postcode: 3015 GD

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2016-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Alzheimer’s disease (AD) affects worldwide ~50 million people. Preclinical research relies mainly on transgenic mouse models overexpressing mutant human proteins that are altered in <5% of AD cases (e.g. β-amyloid and tau), however, despite prominent protein aggregates, they fail to show the dramatic neurodegeneration and cognitive decline of patients, indicating that plaques and tangles may not be the only requirement for AD. Age is the most determining factor in AD, but is poorly represented in current AD models. Generating bona fide mouse models for various human DNA repair syndromes we have disclosed a very strong connection between DNA damage, repair and aging including dramatic neurodegeneration. Within the context of ERC-DamAge we discovered striking parallels in neurodegeneration, progressive cognitive decline and genome-wide expression profiles of repair-deficient Ercc1Δ/- mice and human AD. The similarities in expression profiles are an order of magnitude higher than current AD mouse models. We discovered that nutritional interventions can spectacularly delay neurodegeneration, opening realistic perspectives for combating AD and other neurodegenerative disorders. The primary goal of this application is to complete the characterization of the mouse mutants as a valid model for AD by a detailed quantitative comparison of all RNA classes of relevant brain compartments of Ercc1Δ/- mutants and AD patients. This not only provides the final PoC, but also an unparalleled resource for pathway analysis, target identification and biomarkers for monitoring disease progression and effects of any intervention. This application will be instrumental to facilitate transition to a valid AD model for pharmaceutical companies enabling development of effective medication for prevention and/or therapy. This proposal addresses a huge unmet medical need worldwide, which seriously affects QoL, challenges health care systems, and offers unprecedented socio-economical opportunities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DEMENTIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DEMENTIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ChaperoneRegulome (2020)

ChaperoneRegulome: Understanding cell-type-specificity of chaperone regulation

Read More  

EffectiveTG (2018)

Effective Methods in Tame Geometry and Applications in Arithmetic and Dynamics

Read More  

PSYDISC (2020)

Developing and Testing the Psychological Distance to Science Model

Read More